ARTICLE | Company News
New indication for Remicade in EU
February 5, 2001 8:00 AM UTC
Europe's CPMP approved Centocor's Remicade infliximab in combination with methotrexate to improve physical function and reduce the rate of joint damage in patients with rheumatoid arthritis (RA) who h...